Healthcare · Vaccine antigens production

Vaccine antigens production in Kenya in 2026

Kenya does not yet produce vaccine antigens — in 2026, the figure was 0 million doses. The country is entirely dependent on vaccine imports through international programs such as COVAX and GAVI. However, in 2023, construction began on the first vaccine production plant in Nairobi, supported by WHO and UNICEF. The launch is expected by 2028, which will allow Kenya to join African producers of immunobiologicals. Kenya ranks 72nd out of 197 countries.

Data for 2026 · unit: million doses
Position

Kenya world ranking

#72 / 197

Country position on the scale from last to first place for this indicator.

KE
#72
#197#1
Trend

Change over time

Change in indicator over the available period.

0
1950
0
1990
0
2000
0
2010
0
2020
0
2025
0
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Kenya — how much?
Based on 2026 data — 0 million doses. This is rank #72 out of 197 countries.
What is Kenya's rank by Vaccine antigens production?
Kenya ranks #72 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Kenya?
Over the available period the indicator changed from 0 to 0 million doses.